PMID: 42252304

Repurposing atorvastatin for uterine leiomyosarcoma: mevalonate pathway inhibition yields preclinical antitumor efficacy.

Zhou Fang-Liang, Wu Yi-Bin, Wang Wen, Yan Bin-Jie, He Ying-Chun, Zheng Xi-Long

Acta pharmacologica Sinica · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.